- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07684378
AI Chatbot Education for Improving HPV Knowledge Among University Students (AIHPV)
Effect of an AI Chatbot-Based Educational Program on HPV Knowledge Among University Students
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Study Purpose
The purpose of this study was to evaluate the effectiveness of an AI chatbot-based educational program in improving Human Papillomavirus (HPV) knowledge among undergraduate nursing students.
Study Design
This study was designed as a parallel-group randomized controlled trial conducted among undergraduate nursing students at Cyprus International University, Northern Cyprus. Participants were randomly assigned to either the intervention group (AI chatbot-based personalized education) or the control group (standard written educational materials) using block randomization.
Sample Size
Based on a previous educational intervention study and the two-sample mean comparison formula, with a significance level of 0.05 and a statistical power of 80%, the required sample size was calculated as 30 participants per group. After allowing for a 10% dropout rate, a total of 68 participants were enrolled, with 34 participants allocated to each study group.
Data Collection Tools
Data were collected using:
A demographic questionnaire (age, gender, faculty, year of study, previous HPV education, source of HPV information, and HPV vaccination status).
The validated 29-item HPV Knowledge Questionnaire developed by Waller et al. (2013), assessing general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge.
Intervention
Participants were randomly assigned to one of two groups.
AI Chatbot Group:
Participants received personalized HPV education through an artificial intelligence (AI) chatbot. Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, vaccination, prevention strategies, and common misconceptions.
Control Group:
Participants received standard written educational materials covering the same HPV-related topics without chatbot interaction or personalized educational content.
Outcome Assessment
HPV knowledge was measured before and after the educational intervention using the validated HPV Knowledge Questionnaire.
Ethical Considerations
The study received approval from the Cyprus International University Ethics Review Board (Approval No. EKK25-26/15/08). The study was conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants before enrollment.
Statistical Analysis
Data will be analyzed using SPSS version 26. Descriptive statistics, independent t-tests, paired t-tests, Chi-square tests, Fisher's exact tests, and non-parametric tests will be performed as appropriate. Statistical significance will be be set at a two-sided P value of less than 0.05.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
North Cyprus
-
Nicosia, North Cyprus, Cipro
- Pouran Varvani Farahani
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- All students, both female and male, first semester of bachelor's degree, studying in nursing department Enrollment at Cyprus International University
- Willingness to participate and provide written informed consent
- No prior formal education on HPV
Exclusion Criteria:
- Withdrawal of consent at any stage of the study
- Failure to complete either the pre-test or post-test assessments
- Incomplete participation in the educational intervention
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: AI Chatbot-Based Education
Participants in this group received personalized education about Human Papillomavirus (HPV) through an artificial intelligence (AI) chatbot.
The educational content was tailored according to each participant's baseline HPV knowledge and covered HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions
|
Participants received personalized education through an artificial intelligence (AI) chatbot.
Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions.
The chatbot provided interactive, personalized educational support throughout the intervention
|
|
Comparatore attivo: Standard Written Education
Participants in this group received standard written educational materials covering the same HPV-related topics, including HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies.
No personalized feedback or AI chatbot interaction was provided
|
Participants received standard written educational materials covering HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies.
The educational materials were identical in content to the intervention group but were provided without personalization or AI chatbot interaction
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
HPV Knowledge Score
Lasso di tempo: Baseline (before the educational intervention) and 1 month after completion of the educational intervention.
|
The primary outcome measure assesses changes in participants' knowledge of Human Papillomavirus (HPV) following the educational intervention.
HPV knowledge is measured using the validated 29-item HPV Knowledge Questionnaire developed by Waller et al. (2013).
The questionnaire evaluates three domains: general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge.
Higher total scores indicate greater HPV-related knowledge
|
Baseline (before the educational intervention) and 1 month after completion of the educational intervention.
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Pouran Varvani Farahani, PhD, PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- PVF-HPV-AI-2026
- EKK25-26/15/08 (Altro identificatore: Cyprus International University Ethics Review Board)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su HPV Knowledge
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletatoVaccino HPV | HPVStati Uniti, Porto Rico
-
University of PennsylvaniaWorld Bank GroupNon ancora reclutamento
-
Centre Hospitalier Universitaire de la RéunionReclutamento
-
University of UtahNational Cancer Institute (NCI)Reclutamento
-
East Carolina UniversityReclutamento
-
Fundación HuéspedMSD Pharmaceuticals LLCCompletato
-
Emory UniversityAttivo, non reclutante
-
University of FloridaNational Cancer Institute (NCI)Attivo, non reclutante
-
Medipol Universitygaziantep university medicine facultyCompletato
-
University of MinnesotaCompletato
Prove cliniche su AI Chatbot-Based Education
-
Chia-Tzu LineCompletatoDiabete mellito di tipo 2 (T2DM) | Pazienti diabetici, cura di sé, basato sull'intelligenza artificiale, autoefficaciaCina
-
Selcuk UniversityReclutamento
-
Scripps Whittier Diabetes InstituteReclutamentoDiabete di tipo 2Stati Uniti
-
Hacettepe UniversityCompletatoDiabete di tipo 2Tacchino
-
Emel GÜÇLÜ CİHANKahramanmaras Sutcu Imam UniversityReclutamentoInfezione da papillomavirus umano (HPV). | Accettazione/Intenzione Vaccinazione HPVTurchia (Türkiye)
-
Nordsjaellands HospitalLund University; Region Capital Denmark; Ostfold University College; University College... e altri collaboratoriReclutamentoOspedaleDanimarca, Norvegia, Svezia
-
Tokat Gaziosmanpasa UniversityCompletatoStigmatizzazione | Funzionalità | Supporto tra pari | Disturbi mentali cronici | Formazione sulle abilità psicosociali | IntuizioneTacchino
-
Tulane UniversityUniversity of Alabama at Birmingham; Louisiana State University Health Sciences... e altri collaboratoriTerminatoCOVID-19 | Lupus eritematoso sistemicoStati Uniti
-
The University of Texas Medical Branch, GalvestonIscrizione su invitoFerita da arma da fuocoStati Uniti
-
Distrito Sanitario AlmeriaJunta de AndaluciaCompletatoSalute digitale | Violenza sul posto di lavoro | Professionisti della salute | ChatbotSpagna